Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mutated interleukin-34 (IL-34) polypeptides and uses thereof in therapy

Mutated interleukin-34 (IL-34) polypeptides and uses thereof in therapy

US Patent 12466866 · Granted Nov 11, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-human CD45RC antibodies and uses thereof2024
Anti-human CD45RC antibodies and uses thereof2024
Methods for obtaining regulatory t cells and uses thereof2024
Methods for obtaining regulatory t cells and uses thereof2024
IL-15Rα sushi domain—IL-15 fusion proteins2024
IL-15Rα sushi domain—IL-15 fusion proteins2024
Isolated interleukin-34 polypeptide for use in preventing transplant rejection a2024
Isolated interleukin-34 polypeptide for use in preventing transplant rejection a2024
Method for obtaining T cells from pluripotent stem cells, and uses thereof2024
Inhibitors of RAC1 and uses thereof for treating cancers2023
Pharmaceutical composition comprising IL-34 and a mTOR inhibitor2021
Pharmaceutical composition comprising IL-34 and a mTOR inhibitor2021